Single-cell RNA-sequencing analysis of malignant progression in non-small cell lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047380

Enrollment

Unknown

Registered

2021-06-13

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

case series:Null

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed with non-small cell lung cancer and were hospitalized in our hospital; 2. Has not yet started radiotherapy, chemotherapy or immunotherapy; 3. There is no limit to gender; 4. Sign the informed consent form voluntarily; 5. The age of onset is not limited.

Exclusion criteria

Exclusion criteria: 1. Aged 80 years; 2. Pregnant and lactating patiens; 3. Patients with severe primary diseases such as cardiovascular, liver, kidney, hematopoietic system, and mental illness.

Design outcomes

Primary

Measure	Time frame
cell grouping;cell transcription differences;	—

Countries

China

Contacts

Public ContactTang Hao

Shanghai Changzheng Hospital

tanghao_0921@126.com+86 13816033045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026